This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Assay Development Remove Marketing Remove Pharmacokinetics
article thumbnail

The essential role of recombinant phage display antibody libraries

Drug Target Review

OCTOBER 3, 2024

Overcoming traditional antibody generation limitations with recombinant technologies Antibodies remain essential tools in this ever-changing field for preclinical bioanalysis and drug monitoring through ligand-binding assays (LBAs). Prior to this, he worked at an in vitro immuno-diagnostic company as Strategic Marketing Manager.

Molecular Biology 52
Molecular Biology Pharmacokinetics Laboratories Animal Testing 52
article thumbnail

Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update

Agency IQ

FEBRUARY 2, 2024

The protocol and statistical analysis plan should clearly specify the plans for specimen collection, sample analysis and related clinical outcomes depending on the biomarker assay development and validation strategy. Umbrella trials investigate multiple drugs or drug combinations in one disease. randomized control arms) are met.

Clinical Trials 40
Clinical Trials Trials Treatment Disease 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 15,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024